Dan Ferry
LifeSci (Investor Relations)
Replay available
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) Q2 2025 earnings conference call, held 2025-08-04. Replay captured from the company's public earnings webcast.

LifeSci (Investor Relations)
President and Chief Executive Officer
Chief Financial Officer
Analyst, TD Cowen
Analyst, Piper Sandler
Analyst, Truist Securities
Analyst, Oppenheimer & Co.
Analyst, H.C. Wainwright
Watch the replay and follow the connected company analysis, news, and investor updates for Praxis Precision Medicines, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.115 Good day and thank you for standing by. Welcome to the Praxis Precision Medicine's 00:00:05.115 -- 00:00:10.600 third quarter 2024 corporate update. At this time, all participants are in a listen-only 00:00:10.600 -- 00:00:14.643 mode. Please be advised that today's conference is being recorded. 00:00:14.643 -- 00:00:18.306 After the speaker's presentation, there will be a question and answer session. 00:00:18.306 -- 00:00:22.810 To ask a question, please press star 1-1 on your telephone and wait for your name to 00:00:22.810 -- 00:00:26.674 be announced. To withdraw your question, please press star 1-1 again. 00:00:26.674 -- 00:00:29.933 I would now like to hand the conference over to your speaker today. 00:00:29.933 -- 00:00:33.215 Dan Ferry from LifeSci. 00:00:36.161 -- 00:00:40.667 Good morning, and welcome to the Praxis Precision Medicine's third quarter 2024 financial 00:00:40.667 -- 00:00:43.430 results and business update conference call. 00:00:43.430 -- 00:00:47.215 This call is being webcast live and can be accessed on the investor section of the Praxis 00:00:47.215 -- 00:00:50.596 website at www.praxismedicines.com. 00:00:52.061 -- 00:00:55.565 Please note that remarks made during this call may contain forward-looking statements 00:00:55.565 -- 00:01:00.157 within the meaning of the Private Securities Litigation Reform Act of 1995. 00:01:00.157 -- 00:01:04.543 These may include statements about the company's future expectations and plans, critical 00:01:04.543 -- 00:01:08.108 development timelines, and financial projections. 00:01:08.108 -- 00:01:11.993 While these forward-looking statements represent Praxis's views as of today, they should 00:01:11.993 -- 00:01:15.719 not be relied upon as representing the company's vie...